Blood pressure goal attainment in multi-ethnic Asian patients with hypertension and dyslipidaemia in primary care.
Hypertension and dyslipidaemia are major risk factors for cardiovascular diseases, and achieving treatment goals mitigates such risks. This study determined demographic and medication-related factors associated with blood pressure (BP) goal attainment in patients with concomitant hypertension and dyslipidaemia. This paper consisted of a sub-analysis of the Lipid HEALTH study, a questionnaire survey focusing on adult Asian patients with both dyslipidaemia and hypertension. Interviewer-administered questionnaire was used to obtain information on demographic and clinical information. Laboratory and prescription data was retrieved from electronic health records. BP goals were defined by international guidelines. Data was audited and analysed, followed by logistic regression analysis to identify factors determining BP goal attainment. The complete data of 851 included patients were analysed; 49.7% of them attained their BP goals. 37% were on monotherapy, 57.6% on two or more BP-lowering medications, and 5.5% had no pharmacologic treatment. Among those on pharmacotherapy, 51.2% failed to achieve BP goals. Calcium channel blockers were the most frequently prescribed medications. Attainment of BP goals was significantly associated who had no type 2 diabetes mellitus (DM) (OR 2.27; 95% CI 1.61-3.13); attained low-density lipoprotein cholesterol (LDL-C) goal (OR 2.02; 95% CI 1.45-.81); were solely on dietary control (OR 2.19; 95% CI 1.09-4.39); and received monotherapy (OR 1.71; 95% CI 1.18-2.48). BP treatment goals were attained by half of the patients with dyslipidaemia and hypertension, and half of those on pharmacotherapy. Type 2 DM and LDL-C control were significantly associated with BP goal attainment.